Reza Shojaei: On The 2nd Day of IPAW 2025, Let’s Focus on Patients, The Real Reason Plasma Matters!
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
”On the second day of IPAW 2025, let’s focus on patients, the real reason plasma matters.
Plasma-derived medicines treat life-threatening conditions such as primary immune deficiencies, hemophilia, and hereditary angioedema.
For many, these therapies are not optional; they are the only available treatment, turning what used to be fatal diseases into manageable conditions.
Every donation ensures someone, somewhere, gets another chance at health, at family life, at simply living fully.
Behind each unit of plasma is a powerful chain: a donor’s generosity, a patient’s survival, and then a family’s hope.
Let’s use this week to amplify the voices of patients and remind the world that plasma saves lives every single day.
If you know someone whose life has been touched by plasma therapies, share their story on social media, because awareness grows stronger when it’s personal.”
Stay updated on emerging topics in transfusion medicine with Hemostasis Today.
-
Oct 8, 2025, 03:07Stroke Education By Rodrigo Guerrero - On Unilateral, Nonprogressive Stenosis
-
Oct 7, 2025, 15:015 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
-
Oct 7, 2025, 14:39Dr Amid Karad: Help Raise Awareness on Evidence-Based INR Management for Diverse Indications
-
Oct 7, 2025, 14:27NBCA Insights with Erin VanDyke: Revealing Gaps in Blood Clot Diagnosis and Support
-
Oct 7, 2025, 14:26Caitlin Raymond: When to Use Albumin vs. Plasma, and Why the Timing Matters
-
Oct 8, 2025, 04:50Christopher Cannon Shares A Study Showing No Benefit When Adding an Antiplatelet to Anticoagulant in Stroke with AF and Atherosclerosis
-
Oct 8, 2025, 04:41Claudio Laudani: We Summarize Current Knowledge and Future Perspectives On The Role of Inflammation in Patients with MI
-
Oct 8, 2025, 04:03José Antonio García Erce: Honored For Publishing in SANGRE Magazine
-
Oct 8, 2025, 03:57Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
-
Oct 8, 2025, 03:54Rory R Koenen on Platelet-Derived Extracellular Vesicle Analogues from Lyophilized Platelets
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 8, 2025, 04:45Reza Shojaei: On The 2nd Day of IPAW 2025, Let's Focus on Patients, The Real Reason Plasma Matters!
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
-
Oct 7, 2025, 04:09Svenja Tatjana Barckhausen: Reducing Reliance on U.S. Plasma – Not Just for Europe, But for The World!
-
Oct 7, 2025, 03:58Louise Bannon: Don’t Wait Until You’re Diagnosed to Learn About Blood Clots